A networked system designed to promote patient self-management appears to be safe and effective in capturing, integrating, and presenting medication adherence and physiologic information.
Both potential benefits and unexpected consequences were found as a result of the rollout of electronic prescribing.
This study analyzes various pathways toward hospital adoption of electronic health records and explores relationships among various electronic health record function variables.
Financial incentives may not be strong enough to influence physician goal commitment to guideline-recommended hypertension care when providers attribute performance to forces beyond their control.
Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.
Self-reported health measures embedded in a Medicaid application can comprise a predictive model identifying new and returning enrollees at risk of high healthcare utilization.
Results of our pilot randomized controlled intervention involving emergency department (ED)-based care coordination and community health workers demonstrated a trend toward fewer ED visits, fewer hospitalizations, and lower costs among intervention patients.
Payers like key traits of pragmatic clinical trials, but are wary of pharmaceutical companies and plan to carefully scrutinize this new, appealing type of evidence.
Using a prioritization algorithm in an oncology pharmacy system at the Johns Hopkins University, patient wait times for chemotherapy administration were significantly decreased.
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
A trial of electronic note–based decision support showed small effects on management of patients with heart disease and diabetes, mostly because it was infrequently used.
Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.
Interview with David Siegel, MD, chief of the Division of Multiple Myeloma, John Theurer Cancer Center
Assessment of the timing of histologic and molecular testing indicates that testing occurred prior to treatment initiation for most patients with metastatic non—small cell lung cancer.
Despite their intention to protect against coverage denial and/or premium increases, additional state-level Medigap regulations are correlated with lower Medigap enrollment and stronger moral hazard.
This cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.
A review of exemplary VHA-sponsored telemedicine interventions indicates that telemedicine can efficiently address patient healthcare needs.
Genomics-based precision medicine has the potential to transform healthcare delivery. However, effective collaborations among scientists, clinicians, and payers are needed to accelerate the translation of precision medicine to clinical practice and ensure its sustainability.
To improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.